SEC Filing Summary: Nephros, Inc. (8-K)
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Nephros, Inc. on August 15, 2006. The report addresses a critical regulatory matter regarding the Company's continued listing status on the American Stock Exchange (AMEX).
Key Financial Metrics
The filing does not provide specific revenue, profit, cash flow, or debt figures. However, it references the following financial conditions as the basis for the listing deficiency notice:
- Shareholders' Equity: Reported as less than $4,000,000 (violating Section 1003(a)(ii)) and less than $6,000,000 (violating Section 1003(a)(iii)).
- Profitability: The Company has reported losses from continuing operations and/or net losses in three of its four most recent fiscal years and in its five most recent fiscal years.
Material Changes and Listing Status
On July 17, 2006, the AMEX notified Nephros, Inc. of non-compliance with continued listing standards due to the financial metrics noted above. On August 15, 2006, the AMEX granted the Company a one-week extension until August 24, 2006, to submit a compliance plan detailing actions taken or planned to restore compliance. The plan was originally due on August 17, 2006.
Outlook, Risks, and Management Commentary
Management Action: The Company intends to submit a compliance plan to the AMEX Staff by the new deadline of August 24, 2006.
Risks: The primary risk is the potential delisting from the AMEX if the Company fails to submit an acceptable compliance plan or fails to meet the listing standards within the required timeframe. The filing does not provide specific guidance on future financial performance or operational outlook beyond the immediate listing issue.
Investor Verification Checklist
- Verify the submission status of the compliance plan by the August 24, 2006 deadline.
- Confirm the Company's current shareholders' equity and recent net loss figures in the most recent 10-K or 10-Q filings.
- Monitor for subsequent 8-K filings regarding the AMEX's decision on the compliance plan or potential delisting.
- Review the attached press release (Exhibit 99.1) for additional management commentary on the situation.